1. Home
  2. CASI vs CISO Comparison

CASI vs CISO Comparison

Compare CASI & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • CISO
  • Stock Information
  • Founded
  • CASI 1991
  • CISO 2015
  • Country
  • CASI China
  • CISO United States
  • Employees
  • CASI N/A
  • CISO N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • CASI Health Care
  • CISO Technology
  • Exchange
  • CASI Nasdaq
  • CISO Nasdaq
  • Market Cap
  • CASI 29.0M
  • CISO 31.4M
  • IPO Year
  • CASI 1996
  • CISO N/A
  • Fundamental
  • Price
  • CASI $1.33
  • CISO $1.34
  • Analyst Decision
  • CASI Strong Buy
  • CISO
  • Analyst Count
  • CASI 1
  • CISO 0
  • Target Price
  • CASI $4.00
  • CISO N/A
  • AVG Volume (30 Days)
  • CASI 287.9K
  • CISO 2.1M
  • Earning Date
  • CASI 08-15-2025
  • CISO 08-13-2025
  • Dividend Yield
  • CASI N/A
  • CISO N/A
  • EPS Growth
  • CASI N/A
  • CISO N/A
  • EPS
  • CASI N/A
  • CISO N/A
  • Revenue
  • CASI $31,368,000.00
  • CISO $29,887,603.00
  • Revenue This Year
  • CASI N/A
  • CISO N/A
  • Revenue Next Year
  • CASI N/A
  • CISO N/A
  • P/E Ratio
  • CASI N/A
  • CISO N/A
  • Revenue Growth
  • CASI 8.39
  • CISO N/A
  • 52 Week Low
  • CASI $1.10
  • CISO $0.26
  • 52 Week High
  • CASI $7.67
  • CISO $3.84
  • Technical
  • Relative Strength Index (RSI)
  • CASI 28.60
  • CISO 60.57
  • Support Level
  • CASI $1.10
  • CISO $0.94
  • Resistance Level
  • CASI $2.07
  • CISO $1.07
  • Average True Range (ATR)
  • CASI 0.28
  • CISO 0.11
  • MACD
  • CASI -0.06
  • CISO 0.01
  • Stochastic Oscillator
  • CASI 12.36
  • CISO 86.69

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: